Article: TEMIS Text Analytics Solution Luxid(R) for Automated Knowledge Discovery in Pharma Research.

Pharma Research Uses Luxid(R) Software Solution to Generate and Validate Hypotheses in Drug Discovery and Development Processes

NEW YORK, September 29 /PRNewswire/ -- The strong emphasis that TEMIS, the leading provider of Text Analytics solutions, has put on the Life Science market since many years has led to another important licensing agreement: Merck KGaA decided to deploy TEMIS to support hypothesis generation and validation services of their Research Knowledge Management department.

The generation and validation of hypotheses that drive drug discovery involves constant scanning of massive volumes of scientific literature, patents, adverse event ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!